United States IVD Raw Materials Market Size, Share & Trends Analysis Report By Product (Antibody, Antigens, Proteins, Enzymes, Biological Buffers, Substrates, Others), By Technology (Molecular Diagnostics, Clinical Chemistry, Immunochemistry, Others), By End User (Diagnostic Laboratories, Pharmaceutical & Biotechnological Companies, Others) and Forecasts, 2026-2034

United States Ivd Raw Materials Market Size

The United States IVD Raw Materials Market size was valued at USD 1.94 billion in 2025 and is projected to grow from USD 2.12 billion in 2026 to reach USD 4.24 billion by 2034, growing at a CAGR of 9.08% during the forecast period 2026–2034.

The increasing focus on personalized medicine, advancements in diagnostic tools, and the rising prevalence of chronic diseases are key factors driving market growth. Technological advancements, along with rising investments in research and development (R&D), are further bolstering the development of innovative diagnostic solutions for IVD raw materials in the United States.

Product Type Insights

Antibody dominates the product type segment and is expected to grow at a CAGR of 11.9% over the forecast period. Antibodies are critical to the U.S. IVD raw materials market, primarily used in immunoassays and molecular diagnostics. The demand for monoclonal and polyclonal antibodies is rising due to the increasing prevalence of cancer and autoimmune diseases. Hospitals and diagnostic labs are expanding their use of antibody-based tests, particularly for cancer diagnostics such as immunohistochemistry (IHC), driving growth in this segment.

Request Customizationto receive a tailored report.

Technology Insights

Immunochemistry dominates the technology segment and is expected to grow at a CAGR of 12.3% through 2033. Immunochemistry technologies are widely adopted in point-of-care testing and home diagnostics in the U.S. Their growing popularity is attributed to advancements in automated platforms and reagent systems that reduce diagnostic time and improve accuracy. The high demand for chemiluminescence immunoassays (CLIA) in detecting biomarkers with precision is expected to sustain the segment's growth throughout the forecast period.

End-User Insights

Pharmaceutical and biotechnological companies dominate the end-user segment and is expected to grow at a CAGR of 12.9%. Pharmaceutical and biotechnological companies are significant end-users of IVD raw materials in the U.S., where the push for personalized medicine is accelerating collaborations between diagnostic manufacturers and pharmaceutical firms. This trend is particularly robust in immuno-oncology, where the focus on biomarker-driven drug development is expected to boost demand for high-quality IVD materials in clinical trials.

Speak to an Analystto discuss market opportunities.

United States Ivd Raw Materials Market Regional Insights

The United States IVD raw materials market’s advanced healthcare infrastructure, high investment in biotechnology, and increasing prevalence of chronic diseases are key drivers of market growth. Moreover, the U.S. government’s focus on expanding diagnostic capabilities through personalized medicine and early disease detection has accelerated the demand for high-quality IVD raw materials. The U.S. leads the global market in innovation and development of diagnostic technologies, ensuring a steady demand for key raw materials like antibodies, antigens, and enzymes.

• New York City, with its advanced healthcare infrastructure, remains a crucial player in the adoption of IVD technologies. The city's strong presence of academic research institutions and pharmaceutical companies contributes to the high demand for IVD raw materials. In 2024, NYC saw a 9% increase in diagnostic testing due to expanding its healthcare services and establishing new diagnostic labs.
• Los Angeles, a hub for biotechnology companies, is witnessing strong growth in the demand for molecular diagnostics. The city’s diverse population has spurred the need for advanced testing for genetic disorders and infectious diseases. In 2024, the town reported a 7% increase in healthcare spending, driven by a surge in biotechnology investments and a rising demand for personalized diagnostic tools.
• Chicago’s strategic location as a healthcare and logistics hub makes it an essential market for IVD raw materials. The city has a strong presence of research labs and hospitals that contribute to its demand for diagnostic tools. In 2024, Chicago saw a 10% growth in its diagnostics sector due to the increasing adoption of advanced testing technologies like next-generation sequencing (NGS).
• Houston, home to the Texas Medical Center, significantly contributes to the U.S. IVD market. The city’s focus on medical research and its large population base make it a thriving diagnostic test market. In 2024, Houston witnessed a 12% rise in diagnostic testing, particularly in oncology and infectious diseases.
• San Francisco's strong biotechnology sector and focus on digital health innovation make it a key player in the U.S. IVD market. The city’s emphasis on molecular diagnostics and personalized medicine is expected to result in continued demand for IVD raw materials. In 2024, diagnostic testing in the city grew by 8%, supported by increased investments in biopharmaceutical R&D.

List of Key and Emerging Players in United States IVD Raw Materials Market